In Vivo Dual CAR T Design Opens Tumor Vasculature

Company Academic (China-based group, Nature Communications) Event Type Peer-reviewed publication Modality mRNA-LNP in vivo dual CAR T Asset VEGFR2-directed plus tumor-antigen-directed CAR T populations Target VEGFR2; tumor antigen Disease Area Melanoma and colorectal cancer (mouse models) Summary A peer-reviewed Nature Communications article published online November…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *